Market Research Logo

Honduras Pharmaceuticals and Healthcare Report Q4 2017

Honduras Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

The Honduran pharmaceutical sector will continue to be viewed as an extremely unattractivemarket for multinational drugmakers over our extended forecast period. The country's underdevelopedhealthcare system, weak regulatory environment and low levels of affordability will hold back innovativemedicine sales. We expect low-cost generic medicines will continue to dominate the market as thegovernment looked to improve healthcare coverage within a limited budget.

Headline Expenditure ProjectionsPharmaceuticals: HNL10.70bn (USD467mn) in 2016 to HNL11.11bn (USD457mn) in 2017; +3.8% inlocal currency terms, and -2.1% in US dollar terms. Forecast unchanged from last quarter.Healthcare: HNL40.41bn (USD1.76bn) in 2016 to HNL43.33bn (USD1.78bn) in 2017; +7.2% in localcurrency terms, and +1.1% in US dollar terms. Forecast revised upwards from last quarter.

Latest Updates

In August 2017, the Medical College of Honduras (CMH) held a protest against the continuedprivatisation of healthcare services in the country as well as the ongoing shortages of medicines andmedical staff.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Honduras 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Honduras 2013-2021)
Industry Risk/Reward Index
Americas Pharmaceuticals: Attractiveness To Drugmakers Masks Disparities Between Markets
Regulatory Review
Pricing Regime
Market Overview
Healthcare Sector
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Demographic Forecast
Honduras Demographic Outlook
Table: Population Headline Indicators (Honduras 1990-2025)
Table: Key Population Ratios (Honduras 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Honduras 1990-2025)
Table: Population By Age Group (Honduras 1990-2025)
Table: Population By Age Group % (Honduras 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report